Ozanimod for relapsing‐remitting multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ozanimod for Relapsing‐remitting Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437993/all/Ozanimod_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed 19 April 2024.
Ozanimod for relapsing‐remitting multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437993/all/Ozanimod_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed April 19, 2024.
Ozanimod for relapsing‐remitting multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437993/all/Ozanimod_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_
Ozanimod for Relapsing‐remitting Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437993/all/Ozanimod_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ozanimod for relapsing‐remitting multiple sclerosis
ID - 437993
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437993/all/Ozanimod_for_relapsing‐remitting_multiple_sclerosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -